ANDA 89371, held by IDT Australia. Procainamide Hydrochloride.
As of Nov 21, 2026, ANDA 89371 (Procainamide Hydrochloride), held by IDT Australia, was first approved by FDA on Aug 14, 1987, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 14, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Procainamide Hydrochloride750MG · tablet, extended release;oral | Procainamide Hydrochloride | Discontinued |
| Jan 7, 1992 | Supplement 3Labeling | Approved | None posted |
| Jan 23, 1989 | Supplement 2Labeling | Approved | None posted |
| Nov 29, 1988 | Supplement 1Labeling | Approved | None posted |
| Aug 14, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters